4.84 USD
▼-0.23-4.54%
盘后 6.10 0.00%
2026-09-16
市值
$14.02M
市盈率
—
EPS
-2.86
股息率
—
52 周区间
0.60 – 12.24
成交量
14.24K
Beta
-0.90
目标价
—
52W 低 0.6052W 高 12.24
价格走势
公司简介
Niki BioSolutions, Inc., through its subsidiaries, operates as a clinical-stage biopharmaceutical company and engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in a Phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in a Phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium ...